Elevated glucagon-like peptide-1-(7-36)-amide, but not glucose, associated with hyperinsulinemic compensation for fat feeding

被引:26
作者
Van Citters, GW
Kabir, M
Kim, SP
Mittelman, SD
Dea, MK
Brubaker, PL
Bergman, RN
机构
[1] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90089 USA
[2] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada
关键词
D O I
10.1210/jc.2002-020002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We previously developed a canine model of central obesity and insulin resistance by supplementing the normal chow diet with 2 g cooked bacon grease/kg body weight. Dogs fed this fatty diet maintained glucose tolerance with compensatory hyperinsulinemia. The signal(s) responsible for this up-regulation of plasma insulin is unknown. We hypothesized that meal-derived factors such as glucose, fatty acids, or incretin hormones may signal beta-cell compensation in the fat-fed dog. We fed the same fat-supplemented diet for 12 wk to six dogs and compared metabolic responses with seven control dogs fed a normal diet. Fasting and stimulated fatty acid and glucose-dependent insulinotropic peptide concentrations were not increased by fat feeding, whereas glucose was paradoxically decreased, ruling out those three factors as signals for compensatory hyperinsulinemia. Fasting plasma glucagon-like peptide-1 (GLP-1) concentration was 2.5-fold higher in the fat-fed animals, compared with controls, and 3.4-fold higher after a mixed meal. Additionally, expression of the GLP-1 receptor in whole pancreas was increased 2.3-fold in the fat-fed dogs. The increase in both circulating GLP-1 and its target receptor may have increased beta-cell responsiveness to lower glucose. Glucose is not the primary cause of hyperinsulinemia in the fat-fed dog. Corequisite meal-related signals may be permissive for development of hyperinsulinemia.
引用
收藏
页码:5191 / 5198
页数:8
相关论文
共 72 条
  • [11] INFLUENCE OF GASTRIC-INHIBITORY POLYPEPTIDE ANTISERUM ON GLUCOSE-INDUCED INSULIN-SECRETION IN RATS
    EBERT, R
    CREUTZFELDT, W
    [J]. ENDOCRINOLOGY, 1982, 111 (05) : 1601 - 1606
  • [12] COMPARISON OF THE RELATIONSHIP BETWEEN STRUCTURE AND CNS EFFECTS FOR LORAZEPAM, CLONAZEPAM AND ALPRAZOLAM
    ELLINWOOD, EH
    NIKAIDO, AM
    GUPTA, SK
    HEATHERLY, DG
    HEGE, S
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 1993, 7 (01) : 24 - 32
  • [13] FABER OK, 1979, ACTA MED SCAND, P61
  • [14] GIP AND INSULIN RELEASE IN RELATION TO GASTRIC-EMPTYING OF A MIXED MEAL IN MAN
    FRIED, M
    MAYER, EA
    BLOOM, SR
    TAYLOR, IL
    MEYER, JH
    [J]. REGULATORY PEPTIDES, 1989, 26 (03) : 305 - 312
  • [15] Glucagon-like peptide-1-(7-36) amide and peptide YY mediate intraduodenal fat-induced inhibition of acid secretion in dogs
    Fung, LC
    Chisholm, C
    Greenberg, GR
    [J]. ENDOCRINOLOGY, 1998, 139 (01) : 189 - 194
  • [16] INSULIN SENSITIVITY IN NONDIABETIC RELATIVES OF PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES FROM 2 ETHNIC-GROUPS
    GELDING, SV
    NITHTHYANANTHAN, R
    CHAN, SP
    SKINNER, E
    ROBINSON, S
    GRAY, IP
    MATHER, H
    JOHNSTON, DG
    [J]. CLINICAL ENDOCRINOLOGY, 1994, 40 (01) : 55 - 62
  • [17] THE INCRETIN NOTION AND ITS RELEVANCE TO DIABETES
    HABENER, JF
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1993, 22 (04) : 775 - 794
  • [18] The homeostasis model in the San Antonio Heart Study
    Haffner, SM
    Miettinen, H
    Stern, MP
    [J]. DIABETES CARE, 1997, 20 (07) : 1087 - 1092
  • [19] A prospective analysis of the HOMA model - The Mexico City Diabetes Study
    Haffner, SM
    Gonzalez, C
    Miettinen, H
    Kennedy, E
    Stern, MP
    [J]. DIABETES CARE, 1996, 19 (10) : 1138 - 1141
  • [20] PROSPECTIVE ANALYSIS OF THE INSULIN-RESISTANCE SYNDROME (SYNDROME-X)
    HAFFNER, SM
    VALDEZ, RA
    HAZUDA, HP
    MITCHELL, BD
    MORALES, PA
    STERN, MP
    [J]. DIABETES, 1992, 41 (06) : 715 - 722